CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CRSP CRISPR Therapeutics AG

交易中 12-17 15:09:06 EST

54.95

-1.02

-1.82%

最高58.00	最低54.88	成交量74.71万
今开55.74	昨收55.97	日振幅5.57%
总市值52.37亿	流通市值49.75亿	总股本9,530万
成交额4,226万	换手率0.83%	流通股本9,053万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CRSP","market":"US","secType":"STK","nameCN":"CRISPR Therapeutics AG","latestPrice":54.95,"timestamp":1766002143116,"preClose":55.97,"halted":0,"volume":747129,"delay":0,"floatShares":90533000,"shares":95300233,"eps":-5.583008,"marketStatus":"交易中","change":-1.02,"latestTime":"12-17 15:09:06 EST","open":55.74,"high":58,"low":54.88,"amount":42263186.086695,"amplitude":0.055744,"askPrice":54.97,"askSize":50,"bidPrice":54.87,"bidSize":110,"shortable":3,"etf":0,"ttmEps":-5.583008,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766005200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1476849600000,"exchange":"NASDAQ","adjPreClose":55.97,"preHourTrading":{"tag":"盘前","latestPrice":55.72,"preClose":55.97,"latestTime":"09:29 EST","volume":4937,"amount":277124.52329,"timestamp":1765981754283},"postHourTrading":{"tag":"盘后","latestPrice":55.54,"preClose":55.97,"latestTime":"19:58 EST","volume":20980,"amount":1174304.8536,"timestamp":1765933086684},"volumeRatio":0.609345,"impliedVol":0.6334,"impliedVolPercentile":0.324},"requestUrl":"/m/hq/s/CRSP","defaultTab":"news","newsList":[{"id":"1194188960","title":"美股夜盘｜AI概念股集体走高，CRISPR Therapeutics涨近8%；无人机概念爆发，Ondas Holdings涨超12%","url":"https://stock-news.laohu8.com/highlight/detail?id=1194188960","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1194188960?lang=zh_cn&edition=full","pubTime":"2025-11-10 09:48","pubTimestamp":1762739300,"startTime":"0","endTime":"0","summary":"11月10日，美股夜盘时段，AI概念股集体走高，CRISPR $Therapeutics$涨近8%，$BigBear.ai$、$SoundHound AI$涨超5%，$Tempus AI$、涨超4%，Hims & Hers Health涨超3%；无人机概念走强，$Ondas$ Holdings涨超12%，$Unusual Machines$涨超7%，$Red Cat$涨近5%，$Archer Aviation$涨超3%；核电股多数走高，$NuScale Power$、Nano Nuclear Energy涨超6%，Centrus Energy、$Lightbridge$涨超5%；量子计算概念股普涨，$D-Wave Quantum$、$Quantum Computing$、$Arqit Quantum$、$SEALSQ Corp$涨超3%；","market":"us","thumbnail":"https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/5d1fe578ee46cbe0d24c33435ff25ae5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"953900b5a33d6c6ce418dd845a2b2226","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4611","BK4556","LU1861558580.USD","BK4139","LENZ","BK4588","BK4007","BK4585","CRSP","LU1861559042.SGD"],"gpt_icon":0},{"id":"2579460281","title":"基因编辑公司CRISPR Therapeutics上涨7.2%，Editas Medicine上涨8.3%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2579460281","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579460281?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:56","pubTimestamp":1761919005,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4539","BK4588","BK4556","BK4007","CRSP","LENZ","LU1861558580.USD","BK4585","BK4139","LU1861559042.SGD","BK4611"],"gpt_icon":0},{"id":"2575728538","title":"CRISPR Thera计划出售最多6亿美元的普通股","url":"https://stock-news.laohu8.com/highlight/detail?id=2575728538","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575728538?lang=zh_cn&edition=full","pubTime":"2025-10-16 22:55","pubTimestamp":1760626500,"startTime":"0","endTime":"0","summary":"美股周四早盘，基因编辑公司CRISPR Therapeutics（CRSP）下跌1.7%，此前该公司提交文件，计划出售最多6亿美元的普通股，利用其现有的公开市场销售协议。此举旨在加强其财务状况，以推进其研发管线。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-10-16/doc-infucfik7900230.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4556","BK4611","BK4588","BK4585","LU1861558580.USD","LU1861559042.SGD","CRSP","BK4139"],"gpt_icon":0},{"id":"2573927472","title":"美股部分AI医疗概念股走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2573927472","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573927472?lang=zh_cn&edition=full","pubTime":"2025-10-08 23:14","pubTimestamp":1759936446,"startTime":"0","endTime":"0","summary":"格隆汇10月8日｜Recursion Pharmaceuticals涨超8%，CRISPR Therapeutics涨近7%，Tempus Al涨超3%，Hims & Hers Health涨超2%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008232557a4574674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251008232557a4574674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4196","BK4556","CRSP","HIMS","LU1861559042.SGD","BK4548","RXRX","LU1861558580.USD","BK4139","BK4539","BK4588","BK4609","BK4611"],"gpt_icon":0},{"id":"2568170287","title":"小摩看好CRISPR(CRSP.US)基因编辑管线潜力 首予“增持”评级目标价70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568170287","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568170287?lang=zh_cn&edition=full","pubTime":"2025-09-19 09:01","pubTimestamp":1758243687,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，摩根大通首次对CRISPR Therapeutics给出“增持”评级，并强调该公司凭借其管线潜力在基因编辑领域占据独特优势。该行分析师Brian Cheng在报告中指出，随着公司投资组合接近多个关键发展拐点，CRISPR Therapeutics值得投资者重新关注，目标价设定为70美元。摩根大通在报告中进一步阐释：“我们相信，CRISPR 通过在自身免疫细胞疗法与体内心血管赛道之间取得平衡，已制定正确战略并储备充足资源，可规避部分基因编辑同行所面临的困境。”","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1347083.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["CRSP"],"gpt_icon":0},{"id":"2568400073","title":"Crispr Therapeutics Ag盘中异动 早盘股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2568400073","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568400073?lang=zh_cn&edition=full","pubTime":"2025-09-18 21:53","pubTimestamp":1758203629,"startTime":"0","endTime":"0","summary":"北京时间2025年09月18日21时53分，Crispr Therapeutics Ag股票出现异动，股价快速拉升5.28%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.67%。Crispr Therapeutics Ag公司简介：CRISPR Therapeutics是一家基因编辑公司，专注于开发基于Crispr/Cas9的疗法。Crispr/Cas9代表成簇的规则间隔短回文重复序列/Crispr相关蛋白9，是精确改变基因组DNA特定序列的革命性技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091821534995369f21&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025091821534995369f21&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4611","LU1861559042.SGD","BK4588","LU1861558580.USD","BK4139","CRSP","BK4585","BK4007","BK4556","BK4539"],"gpt_icon":0},{"id":"2559489809","title":"CRISPR Therapeutics（CRSP）涨幅迅速扩大至3.4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2559489809","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2559489809?lang=zh_cn&edition=full","pubTime":"2025-08-16 00:42","pubTimestamp":1755276177,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LENZ","BK4611","LU1861559042.SGD","BK4588","LU1861558580.USD","BK4139","CRSP","BK4585","BK4007","BK4556","BK4539"],"gpt_icon":0},{"id":"2558925516","title":"Crispr Therapeutics Ag8月11日成交额为1.13亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558925516","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558925516?lang=zh_cn&edition=full","pubTime":"2025-08-12 09:50","pubTimestamp":1754963408,"startTime":"0","endTime":"0","summary":"美东时间2025年8月11日，Crispr Therapeutics Ag成交额为1.13亿美元，成交额较昨日增加26.24%，当日成交量为201.43万股。Crispr Therapeutics Ag于2025年8月11日涨0.75%，报55.41美元，该股过去5个交易日跌7.01%，年初至今涨40.78%，过去60日涨55.65%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095015a482f4ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250812095015a482f4ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4585","BK4556","BK4611","CRSP","LU1861559042.SGD","LENZ","LU1861558580.USD","BK4139","BK4539","BK4588","BK4007"],"gpt_icon":0},{"id":"2558101503","title":"Crispr Therapeutics Ag8月8日成交额为8941.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558101503","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558101503?lang=zh_cn&edition=full","pubTime":"2025-08-09 09:50","pubTimestamp":1754704212,"startTime":"0","endTime":"0","summary":"美东时间2025年8月8日，Crispr Therapeutics Ag成交额为8941.56万美元，成交额较昨日减少15.59%，当日成交量为162.34万股。Crispr Therapeutics Ag于2025年8月8日跌1.72%，报55.0美元，该股过去5个交易日跌1.94%，年初至今涨39.74%，过去60日涨47.77%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095015a6dbe694&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250809095015a6dbe694&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4139","BK4585","CRSP","LU1861558580.USD","BK4556","BK4007","LENZ","BK4539","BK4611","LU1861559042.SGD"],"gpt_icon":0},{"id":"2557515004","title":"Crispr Therapeutics Ag8月7日成交额为1.06亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557515004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557515004?lang=zh_cn&edition=full","pubTime":"2025-08-08 09:48","pubTimestamp":1754617735,"startTime":"0","endTime":"0","summary":"美东时间2025年8月7日，Crispr Therapeutics Ag成交额为1.06亿美元，成交额较昨日减少21.96%，当日成交量为190.70万股。Crispr Therapeutics Ag于2025年8月7日跌0.67%，报55.96美元，该股过去5个交易日跌0.53%，年初至今涨42.17%，过去60日涨48.87%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094904a6d9dc5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808094904a6d9dc5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4556","BK4539","BK4588","LU1861559042.SGD","CRSP","LU1861558580.USD","BK4139","BK4585","LENZ","BK4007"],"gpt_icon":0},{"id":"2557584165","title":"Crispr Therapeutics Ag8月6日成交额为1.36亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557584165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557584165?lang=zh_cn&edition=full","pubTime":"2025-08-07 09:47","pubTimestamp":1754531242,"startTime":"0","endTime":"0","summary":"美东时间2025年8月6日，Crispr Therapeutics Ag成交额为1.36亿美元，成交额较昨日减少46.36%，当日成交量为243.16万股。Crispr Therapeutics Ag于2025年8月6日涨1.35%，报56.34美元，该股过去5个交易日跌2.32%，年初至今涨43.14%，过去60日涨58.17%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094727a6d79eac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250807094727a6d79eac&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","CRSP","BK4585","BK4539","LENZ","BK4139","LU1861559042.SGD","BK4588","BK4556","LU1861558580.USD","BK4611"],"gpt_icon":0},{"id":"1135796688","title":"CRISPR Therapeutics夜盘上涨，获“木头姐”增持及机构“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=1135796688","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135796688?lang=zh_cn&edition=full","pubTime":"2025-08-06 10:25","pubTimestamp":1754447112,"startTime":"0","endTime":"0","summary":"这家基因编辑公司的股价上涨势头强劲。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRSP"],"gpt_icon":0},{"id":"2557349572","title":"Crispr Therapeutics Ag8月5日成交额为2.53亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557349572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557349572?lang=zh_cn&edition=full","pubTime":"2025-08-06 09:45","pubTimestamp":1754444738,"startTime":"0","endTime":"0","summary":"美东时间2025年8月5日，Crispr Therapeutics Ag成交额为2.53亿美元，成交额较昨日增加27.45%，当日成交量为454.33万股。Crispr Therapeutics Ag于2025年8月5日跌6.71%，报55.59美元，该股过去5个交易日跌5.81%，年初至今涨41.23%，过去60日涨53.82%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806094545a6d57aa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250806094545a6d57aa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4139","LENZ","BK4588","CRSP","LU1861558580.USD","BK4585","BK4007","LU1861559042.SGD","BK4556","BK4539"],"gpt_icon":0},{"id":"2557935657","title":"Crispr Therapeutics Ag8月4日成交额为1.99亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557935657","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557935657?lang=zh_cn&edition=full","pubTime":"2025-08-05 09:44","pubTimestamp":1754358292,"startTime":"0","endTime":"0","summary":"美东时间2025年8月4日，Crispr Therapeutics Ag成交额为1.99亿美元，成交额较昨日增加19.00%，当日成交量为340.11万股。Crispr Therapeutics Ag于2025年8月4日涨6.24%，报59.59美元，该股过去5个交易日跌6.53%，年初至今涨51.4%，过去60日涨73.99%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805094502a6d3647c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250805094502a6d3647c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4611","BK4585","LENZ","LU1861558580.USD","BK4139","LU1861559042.SGD","BK4007","BK4588","CRSP","BK4539","BK4556"],"gpt_icon":0},{"id":"2556842310","title":"Crispr Therapeutics Ag8月1日成交额为1.67亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556842310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556842310?lang=zh_cn&edition=full","pubTime":"2025-08-02 09:44","pubTimestamp":1754099057,"startTime":"0","endTime":"0","summary":"美东时间2025年8月1日，Crispr Therapeutics Ag成交额为1.67亿美元，成交额较昨日减少10.82%，当日成交量为299.23万股。Crispr Therapeutics Ag于2025年8月1日跌0.3%，报56.09美元，该股过去5个交易日跌13.39%，年初至今涨42.51%，过去60日涨69.15%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802094421a6cea5b1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802094421a6cea5b1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CRSP","BK4539","BK4588","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4139","BK4556","BK4007"],"gpt_icon":0},{"id":"2556688018","title":"Crispr Therapeutics Ag7月31日成交额为1.87亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556688018","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556688018?lang=zh_cn&edition=full","pubTime":"2025-08-01 09:44","pubTimestamp":1754012652,"startTime":"0","endTime":"0","summary":"美东时间2025年7月31日，Crispr Therapeutics Ag成交额为1.87亿美元，成交额较昨日减少2.25%，当日成交量为326.72万股。Crispr Therapeutics Ag于2025年7月31日跌2.46%，报56.26美元，该股过去5个交易日跌14.83%，年初至今涨42.94%，过去60日涨49.55%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801094413a46e9b10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801094413a46e9b10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4588","BK4556","BK4007","CRSP","LENZ","LU1861558580.USD","BK4585","BK4139","LU1861559042.SGD","BK4611"],"gpt_icon":0},{"id":"2555095851","title":"Crispr Therapeutics Ag7月29日成交额为2.52亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555095851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555095851?lang=zh_cn&edition=full","pubTime":"2025-07-30 09:47","pubTimestamp":1753840070,"startTime":"0","endTime":"0","summary":"美东时间2025年7月29日，Crispr Therapeutics Ag成交额为2.52亿美元，成交额较昨日增加132.35%，当日成交量为420.63万股。Crispr Therapeutics Ag于2025年7月29日跌7.42%，报59.02美元，该股过去5个交易日跌10.48%，年初至今涨49.95%，过去60日涨56.43%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730094756a46a8ae5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730094756a46a8ae5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4611","LU1861559042.SGD","BK4588","BK4539","CRSP","BK4139","LENZ","LU1861558580.USD","BK4585","BK4007"],"gpt_icon":0},{"id":"2554718665","title":"Crispr Therapeutics Ag7月25日成交额为1.90亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554718665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554718665?lang=zh_cn&edition=full","pubTime":"2025-07-26 09:47","pubTimestamp":1753494424,"startTime":"0","endTime":"0","summary":"美东时间2025年7月25日，Crispr Therapeutics Ag成交额为1.90亿美元，成交额较昨日减少3.09%，当日成交量为291.50万股。Crispr Therapeutics Ag于2025年7月25日跌1.97%，报64.76美元，该股过去5个交易日跌0.57%，年初至今涨64.53%，过去60日涨73.16%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726094705a6c27314&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726094705a6c27314&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","CRSP","BK4539","BK4588","BK4611","LU1861558580.USD","LU1861559042.SGD","BK4585","BK4139","BK4556","BK4007"],"gpt_icon":1},{"id":"2553224024","title":"Crispr Therapeutics Ag7月23日成交额为2.58亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553224024","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553224024?lang=zh_cn&edition=full","pubTime":"2025-07-24 09:44","pubTimestamp":1753321455,"startTime":"0","endTime":"0","summary":"美东时间2025年7月23日，Crispr Therapeutics Ag成交额为2.58亿美元，成交额较昨日减少5.19%，当日成交量为379.06万股。Crispr Therapeutics Ag于2025年7月23日涨3.35%，报68.14美元，该股过去5个交易日涨23.58%，年初至今涨73.12%，过去60日涨78.05%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724094421a6be8b0e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250724094421a6be8b0e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","BK4588","CRSP","BK4556","BK4585","LENZ","LU1861559042.SGD","BK4539","LU1861558580.USD","BK4611"],"gpt_icon":1},{"id":"2553267141","title":"Crispr Therapeutics Ag7月22日成交额为2.72亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2553267141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553267141?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:43","pubTimestamp":1753234987,"startTime":"0","endTime":"0","summary":"美东时间2025年7月22日，Crispr Therapeutics Ag成交额为2.72亿美元，成交额较昨日减少43.79%，当日成交量为420.56万股。Crispr Therapeutics Ag于2025年7月22日涨0.92%，报65.93美元，该股过去5个交易日涨25.03%，年初至今涨67.51%，过去60日涨68.58%。Crispr/Cas9是成簇的规则间隔短回文重复序列/Crispr相关蛋白9的缩写，是精确改变基因组DNA特定序列的革命性技术。Crispr第一个获批的药物是Casgevy，它是与Vertex制药公司合作开发的，主要针对镰状细胞病和输血依赖型β-地中海贫血，这两种疾病的医疗需求尚未得到满足。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094313a6bc1128&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094313a6bc1128&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4611","LU1861559042.SGD","BK4588","BK4539","CRSP","BK4139","LENZ","LU1861558580.USD","BK4585","BK4007"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.crisprtx.com","stockEarnings":[{"period":"1week","weight":-0.0188},{"period":"1month","weight":0.0655},{"period":"3month","weight":-0.0525},{"period":"6month","weight":0.2597},{"period":"1year","weight":0.2651},{"period":"ytd","weight":0.422}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"CRISPR Therapeutics AG作为一家瑞士股份公司在Inception Genomics AG名下于2013年10月31日注册成立。他们是一家领先的基因研究的公司，专注于CRISPR/Cas9的疗法发展。 CRISPR/ Cas9代表集群，定期相互间隔短回文重复（CRISPR）相关蛋白9，是改变基因的编排，基因组DNA的特定序列过程中的一项革命性的技术。他们正在应用此技术通过破坏，纠正或调节与疾病相关的基因来治疗广泛的稀有或常见的疾病。他们最先进的项目是针对β-地中海贫血和镰状细胞病，这种病症的治疗需要两个满足高医疗需求的血红蛋白。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.086437},{"month":2,"riseRate":0.666667,"avgChangeRate":0.085839},{"month":3,"riseRate":0.222222,"avgChangeRate":-0.093679},{"month":4,"riseRate":0.666667,"avgChangeRate":-0.004907},{"month":5,"riseRate":0.555556,"avgChangeRate":0.088862},{"month":6,"riseRate":0.777778,"avgChangeRate":0.125525},{"month":7,"riseRate":0.777778,"avgChangeRate":0.040401},{"month":8,"riseRate":0.444444,"avgChangeRate":-0.01221},{"month":9,"riseRate":0.222222,"avgChangeRate":-0.057837},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.045012},{"month":11,"riseRate":0.7,"avgChangeRate":0.172836},{"month":12,"riseRate":0.3,"avgChangeRate":-0.058888}],"exchange":"NASDAQ","name":"CRISPR Therapeutics AG","nameEN":"CRISPR Therapeutics AG"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"CRISPR Therapeutics AG,CRSP,CRISPR Therapeutics AG股票,CRISPR Therapeutics AG股票老虎,CRISPR Therapeutics AG股票老虎国际,CRISPR Therapeutics AG行情,CRISPR Therapeutics AG股票行情,CRISPR Therapeutics AG股价,CRISPR Therapeutics AG股市,CRISPR Therapeutics AG股票价格,CRISPR Therapeutics AG股票交易,CRISPR Therapeutics AG股票购买,CRISPR Therapeutics AG股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"CRISPR Therapeutics AG(CRSP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供CRISPR Therapeutics AG(CRSP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}